Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 9.22429745 |
2 | epoxygenase P450 pathway (GO:0019373) | 8.74076484 |
3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.67089759 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.57730904 |
5 | L-phenylalanine catabolic process (GO:0006559) | 7.57730904 |
6 | L-phenylalanine metabolic process (GO:0006558) | 7.24473313 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24473313 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.85210016 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.42045991 |
10 | drug metabolic process (GO:0017144) | 6.26386434 |
11 | oxidative demethylation (GO:0070989) | 6.24064969 |
12 | tryptophan catabolic process (GO:0006569) | 6.19805594 |
13 | indole-containing compound catabolic process (GO:0042436) | 6.19805594 |
14 | indolalkylamine catabolic process (GO:0046218) | 6.19805594 |
15 | kynurenine metabolic process (GO:0070189) | 6.06846497 |
16 | bile acid biosynthetic process (GO:0006699) | 5.99265495 |
17 | tryptophan metabolic process (GO:0006568) | 5.83968173 |
18 | glyoxylate metabolic process (GO:0046487) | 5.79833039 |
19 | urea cycle (GO:0000050) | 5.70918860 |
20 | urea metabolic process (GO:0019627) | 5.70918860 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.63047064 |
22 | negative regulation of fibrinolysis (GO:0051918) | 5.61890311 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.60046925 |
24 | phenylpropanoid metabolic process (GO:0009698) | 5.56328936 |
25 | regulation of fibrinolysis (GO:0051917) | 5.44006567 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.41273216 |
27 | protein carboxylation (GO:0018214) | 5.41273216 |
28 | sulfur amino acid catabolic process (GO:0000098) | 5.40123790 |
29 | cysteine metabolic process (GO:0006534) | 5.36881612 |
30 | complement activation, alternative pathway (GO:0006957) | 5.34006142 |
31 | regulation of protein activation cascade (GO:2000257) | 5.28525220 |
32 | nitrogen cycle metabolic process (GO:0071941) | 5.24894249 |
33 | regulation of plasminogen activation (GO:0010755) | 5.23044614 |
34 | serine family amino acid catabolic process (GO:0009071) | 5.18891747 |
35 | bile acid metabolic process (GO:0008206) | 5.13862980 |
36 | ethanol metabolic process (GO:0006067) | 5.01334299 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.97957975 |
38 | regulation of cholesterol esterification (GO:0010872) | 4.93148220 |
39 | regulation of complement activation (GO:0030449) | 4.93119612 |
40 | reverse cholesterol transport (GO:0043691) | 4.89761236 |
41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89378434 |
42 | negative regulation of hemostasis (GO:1900047) | 4.84917746 |
43 | negative regulation of blood coagulation (GO:0030195) | 4.84917746 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.83293999 |
45 | tyrosine metabolic process (GO:0006570) | 4.82724979 |
46 | protein-lipid complex remodeling (GO:0034368) | 4.81706793 |
47 | macromolecular complex remodeling (GO:0034367) | 4.81706793 |
48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81706793 |
49 | homocysteine metabolic process (GO:0050667) | 4.76608500 |
50 | regulation of humoral immune response (GO:0002920) | 4.67467736 |
51 | alpha-amino acid catabolic process (GO:1901606) | 4.66046379 |
52 | amino-acid betaine metabolic process (GO:0006577) | 4.65748003 |
53 | triglyceride homeostasis (GO:0070328) | 4.62662002 |
54 | acylglycerol homeostasis (GO:0055090) | 4.62662002 |
55 | negative regulation of cholesterol transport (GO:0032375) | 4.62317679 |
56 | negative regulation of sterol transport (GO:0032372) | 4.62317679 |
57 | phospholipid efflux (GO:0033700) | 4.61005599 |
58 | lysine catabolic process (GO:0006554) | 4.58788667 |
59 | lysine metabolic process (GO:0006553) | 4.58788667 |
60 | alkaloid metabolic process (GO:0009820) | 4.51810671 |
61 | cellular ketone body metabolic process (GO:0046950) | 4.51009813 |
62 | negative regulation of protein activation cascade (GO:2000258) | 4.49720041 |
63 | acute-phase response (GO:0006953) | 4.49416413 |
64 | S-adenosylmethionine metabolic process (GO:0046500) | 4.49405414 |
65 | glycine metabolic process (GO:0006544) | 4.48185037 |
66 | plasma lipoprotein particle clearance (GO:0034381) | 4.43981535 |
67 | bile acid and bile salt transport (GO:0015721) | 4.42592056 |
68 | opsonization (GO:0008228) | 4.42343324 |
69 | negative regulation of coagulation (GO:0050819) | 4.40096937 |
70 | indolalkylamine metabolic process (GO:0006586) | 4.39616198 |
71 | imidazole-containing compound metabolic process (GO:0052803) | 4.38945859 |
72 | cellular glucuronidation (GO:0052695) | 4.36957572 |
73 | negative regulation of wound healing (GO:0061045) | 4.36897171 |
74 | coenzyme catabolic process (GO:0009109) | 4.35879430 |
75 | amine catabolic process (GO:0009310) | 4.30868648 |
76 | cellular biogenic amine catabolic process (GO:0042402) | 4.30868648 |
77 | cellular amino acid catabolic process (GO:0009063) | 4.29020870 |
78 | cholesterol efflux (GO:0033344) | 4.25212878 |
79 | glutamate metabolic process (GO:0006536) | 4.22307869 |
80 | positive regulation of blood coagulation (GO:0030194) | 4.21738302 |
81 | positive regulation of hemostasis (GO:1900048) | 4.21738302 |
82 | serine family amino acid metabolic process (GO:0009069) | 4.21290199 |
83 | hormone catabolic process (GO:0042447) | 4.19416945 |
84 | benzene-containing compound metabolic process (GO:0042537) | 4.18831639 |
85 | aldehyde catabolic process (GO:0046185) | 4.11840996 |
86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.10080392 |
87 | ethanol oxidation (GO:0006069) | 4.09967474 |
88 | arginine metabolic process (GO:0006525) | 4.04852229 |
89 | cellular modified amino acid catabolic process (GO:0042219) | 4.03699512 |
90 | fibrinolysis (GO:0042730) | 4.03274056 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 4.02910906 |
92 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.01715546 |
93 | plasma lipoprotein particle assembly (GO:0034377) | 4.00446846 |
94 | drug catabolic process (GO:0042737) | 3.96666707 |
95 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.94156171 |
96 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.94156171 |
97 | glucuronate metabolic process (GO:0019585) | 3.90642100 |
98 | uronic acid metabolic process (GO:0006063) | 3.90642100 |
99 | ketone body metabolic process (GO:1902224) | 3.90240281 |
100 | positive regulation of coagulation (GO:0050820) | 3.87404751 |
101 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86470065 |
102 | cofactor catabolic process (GO:0051187) | 3.82907653 |
103 | positive regulation of lipid catabolic process (GO:0050996) | 3.80868335 |
104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.80092027 |
105 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.80092027 |
106 | negative regulation of complement activation (GO:0045916) | 3.80027127 |
107 | flavonoid metabolic process (GO:0009812) | 3.76664935 |
108 | organic acid catabolic process (GO:0016054) | 3.75997821 |
109 | carboxylic acid catabolic process (GO:0046395) | 3.75997821 |
110 | negative regulation of lipase activity (GO:0060192) | 3.75480284 |
111 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75084733 |
112 | cholesterol homeostasis (GO:0042632) | 3.74738549 |
113 | complement activation, classical pathway (GO:0006958) | 3.73615441 |
114 | regulation of bile acid biosynthetic process (GO:0070857) | 3.73185480 |
115 | phospholipid homeostasis (GO:0055091) | 3.71665859 |
116 | complement activation (GO:0006956) | 3.71485176 |
117 | protein activation cascade (GO:0072376) | 3.71223277 |
118 | sterol homeostasis (GO:0055092) | 3.68598297 |
119 | short-chain fatty acid metabolic process (GO:0046459) | 3.67125058 |
120 | response to mercury ion (GO:0046689) | 3.65025555 |
121 | plasma lipoprotein particle organization (GO:0071827) | 3.64920840 |
122 | acetyl-CoA metabolic process (GO:0006084) | 3.64243100 |
123 | NAD biosynthetic process (GO:0009435) | 3.63833395 |
124 | heme transport (GO:0015886) | 3.63326194 |
125 | cytolysis (GO:0019835) | 3.61526753 |
126 | regulation of cholesterol homeostasis (GO:2000188) | 3.61112221 |
127 | steroid catabolic process (GO:0006706) | 3.60707915 |
128 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.59876880 |
129 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.58785327 |
130 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.58785327 |
131 | regulation of lipoprotein particle clearance (GO:0010984) | 3.54960338 |
132 | xenobiotic metabolic process (GO:0006805) | 3.52038872 |
133 | acute inflammatory response (GO:0002526) | 3.50281871 |
134 | intestinal cholesterol absorption (GO:0030299) | 3.43315448 |
135 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.41442571 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.42538945 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.20844811 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.12332091 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50790344 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31240617 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.16553920 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.82053005 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.05505155 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02239034 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06541919 |
11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9937001 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99215762 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94491121 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56424390 |
15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56091427 |
16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50593183 |
17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39935930 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30896026 |
19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27002174 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24854676 |
21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24850552 |
22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22595975 |
23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15755440 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.08247289 |
25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05535566 |
26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.04816759 |
27 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03198671 |
28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00337350 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99161673 |
30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97576749 |
31 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.97323661 |
32 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93281661 |
33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93106383 |
34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90657093 |
35 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.88934959 |
36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.87772743 |
37 | NFYA_21822215_ChIP-Seq_K562_Human | 0.85407781 |
38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85014231 |
39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83738444 |
40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83336708 |
41 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.83076533 |
42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83032075 |
43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82874329 |
44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80702475 |
45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80232306 |
46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78357960 |
47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77250750 |
48 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.76899829 |
49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76795225 |
50 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75198228 |
51 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.75190577 |
52 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74817838 |
53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74264014 |
54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73867198 |
55 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73647862 |
56 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.72673780 |
57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72580349 |
58 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71584840 |
59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71167083 |
60 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.70487402 |
61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68867340 |
62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68426579 |
63 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.68316561 |
64 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.66874767 |
65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66109259 |
66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66109259 |
67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66028403 |
68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64713041 |
69 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64488461 |
70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.63673005 |
71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63658925 |
72 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63543405 |
73 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.62994920 |
74 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.62346521 |
75 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.61713488 |
76 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61532910 |
77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.60871063 |
78 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.60116300 |
79 | NFYB_21822215_ChIP-Seq_K562_Human | 0.59374776 |
80 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58875490 |
81 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.58689295 |
82 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58604769 |
83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.58295761 |
84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58111740 |
85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56908096 |
86 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.56819273 |
87 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54531087 |
88 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.54423898 |
89 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.53823004 |
90 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.53699163 |
91 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.53090063 |
92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.52910534 |
93 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.52680492 |
94 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.52429546 |
95 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.51848496 |
96 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51625848 |
97 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51573094 |
98 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51344006 |
99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51265037 |
100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.51160107 |
101 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51142204 |
102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.50912920 |
103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.50461324 |
104 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50395634 |
105 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49740376 |
106 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.49223818 |
107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.49018963 |
108 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.47992159 |
109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.47986357 |
110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46711897 |
111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46430650 |
112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45973077 |
113 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44158987 |
114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43587419 |
115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43324968 |
116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41957216 |
117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41613177 |
118 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40225123 |
119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40027333 |
120 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39563522 |
121 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39540947 |
122 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.39228662 |
123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39125160 |
124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38698560 |
125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38221342 |
126 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.37572537 |
127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37280406 |
128 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36820667 |
129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36706625 |
130 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36697944 |
131 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.36662155 |
132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36519079 |
133 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.35627591 |
134 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.35474565 |
135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35347215 |
136 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.35086518 |
137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.34268399 |
138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.34226904 |
139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33728706 |
140 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33203627 |
141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.32873618 |
142 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32827412 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.32727270 |
2 | MP0005360_urolithiasis | 7.50672256 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.42500174 |
4 | MP0005365_abnormal_bile_salt | 6.15378284 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.24012859 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.39777026 |
7 | MP0003252_abnormal_bile_duct | 3.89052039 |
8 | MP0010329_abnormal_lipoprotein_level | 3.56829943 |
9 | MP0009840_abnormal_foam_cell | 3.29720362 |
10 | MP0005083_abnormal_biliary_tract | 3.05565550 |
11 | MP0003195_calcinosis | 2.89187758 |
12 | MP0005332_abnormal_amino_acid | 2.75608904 |
13 | MP0001666_abnormal_nutrient_absorption | 2.54553360 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.28167613 |
15 | MP0000609_abnormal_liver_physiology | 2.16104898 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.13690080 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.08406198 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.95512869 |
19 | MP0003868_abnormal_feces_composition | 1.88709745 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84726302 |
21 | MP0001764_abnormal_homeostasis | 1.68634256 |
22 | MP0009697_abnormal_copulation | 1.60099410 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56686037 |
24 | MP0005451_abnormal_body_composition | 1.51160654 |
25 | MP0003186_abnormal_redox_activity | 1.39477263 |
26 | MP0003011_delayed_dark_adaptation | 1.33895456 |
27 | MP0003656_abnormal_erythrocyte_physiolo | 1.24273859 |
28 | MP0009643_abnormal_urine_homeostasis | 1.22615322 |
29 | MP0000598_abnormal_liver_morphology | 1.17677712 |
30 | MP0005647_abnormal_sex_gland | 1.14720177 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.14000186 |
32 | MP0009764_decreased_sensitivity_to | 1.12144650 |
33 | MP0000604_amyloidosis | 1.06889288 |
34 | MP0009763_increased_sensitivity_to | 1.05030869 |
35 | MP0002254_reproductive_system_inflammat | 0.99568161 |
36 | MP0005187_abnormal_penis_morphology | 0.94117279 |
37 | MP0008469_abnormal_protein_level | 0.92374111 |
38 | MP0010368_abnormal_lymphatic_system | 0.91963545 |
39 | MP0005636_abnormal_mineral_homeostasis | 0.89793546 |
40 | MP0005408_hypopigmentation | 0.88422164 |
41 | MP0009642_abnormal_blood_homeostasis | 0.86898594 |
42 | MP0001915_intracranial_hemorrhage | 0.83817187 |
43 | MP0006036_abnormal_mitochondrial_physio | 0.82514106 |
44 | MP0005376_homeostasis/metabolism_phenot | 0.81991676 |
45 | MP0009765_abnormal_xenobiotic_induced | 0.81028613 |
46 | MP0002876_abnormal_thyroid_physiology | 0.77356984 |
47 | MP0002078_abnormal_glucose_homeostasis | 0.76435118 |
48 | MP0005670_abnormal_white_adipose | 0.75190365 |
49 | MP0005084_abnormal_gallbladder_morpholo | 0.73934073 |
50 | MP0002282_abnormal_trachea_morphology | 0.72746310 |
51 | MP0002971_abnormal_brown_adipose | 0.69757931 |
52 | MP0003690_abnormal_glial_cell | 0.69661071 |
53 | MP0005266_abnormal_metabolism | 0.69310799 |
54 | MP0005535_abnormal_body_temperature | 0.67700194 |
55 | MP0005334_abnormal_fat_pad | 0.67554274 |
56 | MP0009053_abnormal_anal_canal | 0.67209735 |
57 | MP0005220_abnormal_exocrine_pancreas | 0.67117631 |
58 | MP0004130_abnormal_muscle_cell | 0.66751471 |
59 | MP0003879_abnormal_hair_cell | 0.64681723 |
60 | MP0001661_extended_life_span | 0.64335900 |
61 | MP0003329_amyloid_beta_deposits | 0.59113780 |
62 | MP0000639_abnormal_adrenal_gland | 0.58781443 |
63 | MP0001756_abnormal_urination | 0.57731978 |
64 | MP0006035_abnormal_mitochondrial_morpho | 0.56913864 |
65 | MP0005464_abnormal_platelet_physiology | 0.55990040 |
66 | MP0002249_abnormal_larynx_morphology | 0.55341648 |
67 | MP0005448_abnormal_energy_balance | 0.53378957 |
68 | MP0003436_decreased_susceptibility_to | 0.51620460 |
69 | MP0003718_maternal_effect | 0.51288709 |
70 | MP0005395_other_phenotype | 0.50767724 |
71 | MP0004782_abnormal_surfactant_physiolog | 0.47902677 |
72 | MP0003724_increased_susceptibility_to | 0.47344120 |
73 | MP0008873_increased_physiological_sensi | 0.46581963 |
74 | MP0008874_decreased_physiological_sensi | 0.46196439 |
75 | MP0002136_abnormal_kidney_physiology | 0.46056678 |
76 | MP0003638_abnormal_response/metabolism_ | 0.45670286 |
77 | MP0002928_abnormal_bile_duct | 0.44579999 |
78 | MP0006082_CNS_inflammation | 0.44577265 |
79 | MP0003075_altered_response_to | 0.44405681 |
80 | MP0002822_catalepsy | 0.43834281 |
81 | MP0009785_altered_susceptibility_to | 0.43315035 |
82 | MP0005023_abnormal_wound_healing | 0.42753735 |
83 | MP0005248_abnormal_Harderian_gland | 0.42647750 |
84 | MP0005166_decreased_susceptibility_to | 0.40559139 |
85 | MP0003953_abnormal_hormone_level | 0.39363001 |
86 | MP0008872_abnormal_physiological_respon | 0.38552928 |
87 | MP0002837_dystrophic_cardiac_calcinosis | 0.36855534 |
88 | MP0001853_heart_inflammation | 0.36491686 |
89 | MP0004381_abnormal_hair_follicle | 0.35567427 |
90 | MP0005666_abnormal_adipose_tissue | 0.33923065 |
91 | MP0009672_abnormal_birth_weight | 0.33454390 |
92 | MP0009115_abnormal_fat_cell | 0.33277474 |
93 | MP0000249_abnormal_blood_vessel | 0.33173121 |
94 | MP0004883_abnormal_blood_vessel | 0.32760675 |
95 | MP0010386_abnormal_urinary_bladder | 0.32227051 |
96 | MP0000579_abnormal_nail_morphology | 0.32220621 |
97 | MP0001845_abnormal_inflammatory_respons | 0.32160655 |
98 | MP0002168_other_aberrant_phenotype | 0.31541023 |
99 | MP0001243_abnormal_dermal_layer | 0.30558388 |
100 | MP0002796_impaired_skin_barrier | 0.29926711 |
101 | MP0002970_abnormal_white_adipose | 0.28890196 |
102 | MP0002132_abnormal_respiratory_system | 0.28827565 |
103 | MP0000230_abnormal_systemic_arterial | 0.28566803 |
104 | MP0002332_abnormal_exercise_endurance | 0.28280950 |
105 | MP0001881_abnormal_mammary_gland | 0.28229476 |
106 | MP0005167_abnormal_blood-brain_barrier | 0.28134480 |
107 | MP0005164_abnormal_response_to | 0.27125075 |
108 | MP0005058_abnormal_lysosome_morphology | 0.25500279 |
109 | MP0003959_abnormal_lean_body | 0.25036460 |
110 | MP0000467_abnormal_esophagus_morphology | 0.24789366 |
111 | MP0002090_abnormal_vision | 0.23748230 |
112 | MP0005197_abnormal_uvea_morphology | 0.21613201 |
113 | MP0004272_abnormal_basement_membrane | 0.20711295 |
114 | MP0001986_abnormal_taste_sensitivity | 0.20464291 |
115 | MP0001851_eye_inflammation | 0.19706618 |
116 | MP0001545_abnormal_hematopoietic_system | 0.19391402 |
117 | MP0005397_hematopoietic_system_phenotyp | 0.19391402 |
118 | MP0004043_abnormal_pH_regulation | 0.18766225 |
119 | MP0002128_abnormal_blood_circulation | 0.17856692 |
120 | MP0000566_synostosis | 0.17566321 |
121 | MP0003633_abnormal_nervous_system | 0.15648627 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.46606167 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.45177433 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.33714254 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.76320314 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 6.64157862 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.47021223 |
7 | Xanthomatosis (HP:0000991) | 6.29801045 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.60312908 |
9 | Complement deficiency (HP:0004431) | 5.31224412 |
10 | Joint hemorrhage (HP:0005261) | 4.88289199 |
11 | Hypolipoproteinemia (HP:0010981) | 4.81578942 |
12 | Hyperammonemia (HP:0001987) | 4.62694879 |
13 | Epidermoid cyst (HP:0200040) | 4.52940986 |
14 | Hyperglycinemia (HP:0002154) | 4.47521894 |
15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.43931293 |
16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40361673 |
17 | Abnormality of methionine metabolism (HP:0010901) | 4.34958740 |
18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.29199533 |
19 | Ketosis (HP:0001946) | 4.25096675 |
20 | Hypoalphalipoproteinemia (HP:0003233) | 4.20000728 |
21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17794367 |
22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.16764161 |
23 | Fat malabsorption (HP:0002630) | 4.16424492 |
24 | Hyperglycinuria (HP:0003108) | 3.98762758 |
25 | Abnormality of glycine metabolism (HP:0010895) | 3.95143615 |
26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95143615 |
27 | Abnormality of complement system (HP:0005339) | 3.90071501 |
28 | Hypoglycemic coma (HP:0001325) | 3.86284678 |
29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77602509 |
30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70820463 |
31 | Hypercholesterolemia (HP:0003124) | 3.68076246 |
32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38688309 |
33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37147861 |
34 | Hyperbilirubinemia (HP:0002904) | 3.34841641 |
35 | Steatorrhea (HP:0002570) | 3.17477051 |
36 | * Abnormality of pyrimidine metabolism (HP:0004353) | 3.14637667 |
37 | Delayed CNS myelination (HP:0002188) | 3.14445955 |
38 | Abnormality of serum amino acid levels (HP:0003112) | 3.11015739 |
39 | Ketoacidosis (HP:0001993) | 3.01115801 |
40 | Hepatocellular carcinoma (HP:0001402) | 3.00478328 |
41 | Myocardial infarction (HP:0001658) | 2.99911334 |
42 | Spontaneous abortion (HP:0005268) | 2.99801720 |
43 | Hypochromic microcytic anemia (HP:0004840) | 2.99497946 |
44 | Osteomalacia (HP:0002749) | 2.97434268 |
45 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.82667421 |
46 | Reduced antithrombin III activity (HP:0001976) | 2.80472748 |
47 | Skin nodule (HP:0200036) | 2.77689126 |
48 | Systemic lupus erythematosus (HP:0002725) | 2.76944512 |
49 | Abnormality of purine metabolism (HP:0004352) | 2.68135492 |
50 | Neonatal hypoglycemia (HP:0001998) | 2.64353678 |
51 | * Metabolic acidosis (HP:0001942) | 2.61513423 |
52 | Vascular calcification (HP:0004934) | 2.60452546 |
53 | Dicarboxylic aciduria (HP:0003215) | 2.60232172 |
54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60232172 |
55 | Purpura (HP:0000979) | 2.56534155 |
56 | Fair hair (HP:0002286) | 2.56272520 |
57 | Glomerulonephritis (HP:0000099) | 2.52786765 |
58 | Spastic diplegia (HP:0001264) | 2.51954819 |
59 | * Lethargy (HP:0001254) | 2.51071901 |
60 | Pulmonary embolism (HP:0002204) | 2.50575081 |
61 | Acanthocytosis (HP:0001927) | 2.49314032 |
62 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49155220 |
63 | Hypoglycemic seizures (HP:0002173) | 2.45703456 |
64 | Abnormal gallbladder morphology (HP:0012437) | 2.45503985 |
65 | Cerebral edema (HP:0002181) | 2.43556017 |
66 | Gout (HP:0001997) | 2.41750464 |
67 | Mitral stenosis (HP:0001718) | 2.41143504 |
68 | Cholelithiasis (HP:0001081) | 2.39370855 |
69 | Irritability (HP:0000737) | 2.38160286 |
70 | Neonatal onset (HP:0003623) | 2.34574918 |
71 | Abnormal gallbladder physiology (HP:0012438) | 2.30743839 |
72 | Cholecystitis (HP:0001082) | 2.30743839 |
73 | Malnutrition (HP:0004395) | 2.30471231 |
74 | Cardiovascular calcification (HP:0011915) | 2.30132373 |
75 | Amyloidosis (HP:0011034) | 2.28548174 |
76 | Elevated alkaline phosphatase (HP:0003155) | 2.24578280 |
77 | Esophageal varix (HP:0002040) | 2.23599709 |
78 | Gingival bleeding (HP:0000225) | 2.23080922 |
79 | Menorrhagia (HP:0000132) | 2.19077703 |
80 | Hyperphosphaturia (HP:0003109) | 2.18077337 |
81 | Pancreatitis (HP:0001733) | 2.16363904 |
82 | Sensorimotor neuropathy (HP:0007141) | 2.14053739 |
83 | Brushfield spots (HP:0001088) | 2.11413292 |
84 | Thrombophlebitis (HP:0004418) | 2.10393021 |
85 | Late onset (HP:0003584) | 2.09491475 |
86 | Arthropathy (HP:0003040) | 2.08934717 |
87 | Generalized aminoaciduria (HP:0002909) | 2.08001128 |
88 | Enlarged kidneys (HP:0000105) | 2.07959129 |
89 | Vomiting (HP:0002013) | 2.07252606 |
90 | Hemorrhage of the eye (HP:0011885) | 2.04700611 |
91 | Opisthotonus (HP:0002179) | 2.04568923 |
92 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.03770148 |
93 | Abnormality of the Achilles tendon (HP:0005109) | 2.00279617 |
94 | Poikilocytosis (HP:0004447) | 1.99788494 |
95 | Glycosuria (HP:0003076) | 1.99513049 |
96 | Abnormality of urine glucose concentration (HP:0011016) | 1.99513049 |
97 | Abnormality of the gallbladder (HP:0005264) | 1.98499331 |
98 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98269805 |
99 | Rickets (HP:0002748) | 1.97120948 |
100 | Abnormal biliary tract physiology (HP:0012439) | 1.94968259 |
101 | Bile duct proliferation (HP:0001408) | 1.94968259 |
102 | Abnormality of iron homeostasis (HP:0011031) | 1.91664550 |
103 | Abnormality of proline metabolism (HP:0010907) | 1.89686524 |
104 | Hydroxyprolinuria (HP:0003080) | 1.89686524 |
105 | Abnormal cartilage morphology (HP:0002763) | 1.88783375 |
106 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88567316 |
107 | Renal cortical cysts (HP:0000803) | 1.88184434 |
108 | Increased serum ferritin (HP:0003281) | 1.88150875 |
109 | Hypophosphatemic rickets (HP:0004912) | 1.85207142 |
110 | Gangrene (HP:0100758) | 1.84515194 |
111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82931240 |
112 | Alkalosis (HP:0001948) | 1.82673156 |
113 | Elevated hepatic transaminases (HP:0002910) | 1.82056294 |
114 | Status epilepticus (HP:0002133) | 1.79786489 |
115 | Nephritis (HP:0000123) | 1.78721240 |
116 | Atrioventricular block (HP:0001678) | 1.77990378 |
117 | Generalized hypopigmentation of hair (HP:0011358) | 1.76915323 |
118 | Abnormal urine phosphate concentration (HP:0012599) | 1.76096586 |
119 | Abnormality of vitamin metabolism (HP:0100508) | 1.75965627 |
120 | Epistaxis (HP:0000421) | 1.75394904 |
121 | Joint swelling (HP:0001386) | 1.72211346 |
122 | Acute hepatic failure (HP:0006554) | 1.70718755 |
123 | Increased mean platelet volume (HP:0011877) | 1.68880873 |
124 | Bifid scrotum (HP:0000048) | 1.62833646 |
125 | Cerebral palsy (HP:0100021) | 1.55528031 |
126 | Blue irides (HP:0000635) | 1.54044233 |
127 | Hypophosphatemia (HP:0002148) | 1.53904934 |
128 | Impaired platelet aggregation (HP:0003540) | 1.53171034 |
129 | Abnormal platelet function (HP:0011869) | 1.53171034 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.31086796 |
2 | FGFR4 | 4.62723299 |
3 | SIK1 | 4.53644339 |
4 | ERN1 | 4.26107601 |
5 | TAOK3 | 3.06730179 |
6 | WNK3 | 3.06373070 |
7 | ERBB4 | 2.97687262 |
8 | INSRR | 2.84879791 |
9 | PIK3CA | 2.38626774 |
10 | MAP2K4 | 2.31553595 |
11 | PKN2 | 2.18843712 |
12 | MST1R | 2.13375000 |
13 | FLT3 | 1.95504595 |
14 | PIK3CG | 1.82297871 |
15 | MAPK11 | 1.82098679 |
16 | TYK2 | 1.79147688 |
17 | ABL2 | 1.62818341 |
18 | LATS1 | 1.59154243 |
19 | TRIB3 | 1.55585400 |
20 | PRPF4B | 1.51338306 |
21 | DAPK2 | 1.46133347 |
22 | NEK9 | 1.39070961 |
23 | MAP3K14 | 1.36604781 |
24 | PTK6 | 1.35074309 |
25 | MYLK | 1.33943904 |
26 | KDR | 1.27789118 |
27 | TNK2 | 1.26930579 |
28 | PINK1 | 1.26706862 |
29 | FRK | 1.26395102 |
30 | JAK2 | 1.24665821 |
31 | NLK | 1.20964211 |
32 | NTRK3 | 1.20611991 |
33 | TBK1 | 1.19823883 |
34 | FGFR2 | 1.19075471 |
35 | MAP2K3 | 1.11309632 |
36 | MAP3K7 | 1.10465205 |
37 | OXSR1 | 1.08853565 |
38 | PRKG1 | 1.06492403 |
39 | PRKAA2 | 1.06208077 |
40 | JAK1 | 1.03533995 |
41 | GRK6 | 1.03337469 |
42 | PDK2 | 1.02399363 |
43 | MAP3K3 | 0.97886988 |
44 | MAPK4 | 0.96590220 |
45 | ARAF | 0.96329130 |
46 | ERBB2 | 0.96063345 |
47 | PRKACA | 0.95741806 |
48 | STK38L | 0.95422687 |
49 | MAP3K10 | 0.94448749 |
50 | PRKCZ | 0.93382797 |
51 | PBK | 0.93189228 |
52 | BLK | 0.91301177 |
53 | MAP3K11 | 0.91100270 |
54 | MAP3K2 | 0.87621310 |
55 | MAPK15 | 0.86422304 |
56 | CDK6 | 0.85420777 |
57 | IRAK3 | 0.84844255 |
58 | MET | 0.84588467 |
59 | EPHB1 | 0.82899427 |
60 | EPHA3 | 0.81808432 |
61 | FER | 0.80845887 |
62 | CSK | 0.79142454 |
63 | CSNK1D | 0.77647775 |
64 | SCYL2 | 0.76934346 |
65 | MAPK12 | 0.76354819 |
66 | PRKACG | 0.74660055 |
67 | SGK1 | 0.73156231 |
68 | MUSK | 0.70830649 |
69 | TIE1 | 0.70533987 |
70 | DYRK1B | 0.70466701 |
71 | STK38 | 0.67316902 |
72 | IKBKE | 0.65931897 |
73 | GSK3A | 0.65727093 |
74 | PRKCB | 0.65717109 |
75 | MAP2K6 | 0.65460816 |
76 | ZAP70 | 0.65052817 |
77 | CAMK2G | 0.64027269 |
78 | RPS6KA3 | 0.63231869 |
79 | RIPK1 | 0.62981994 |
80 | PRKAA1 | 0.61435319 |
81 | MAP3K13 | 0.60797166 |
82 | MAPK7 | 0.58741987 |
83 | FGFR3 | 0.58147011 |
84 | SGK3 | 0.57639735 |
85 | CSF1R | 0.56719698 |
86 | CAMKK2 | 0.56611260 |
87 | CAMK1D | 0.56538475 |
88 | TAOK2 | 0.55359097 |
89 | PRKACB | 0.53724472 |
90 | MAP3K12 | 0.53270079 |
91 | PRKCQ | 0.52005239 |
92 | MAP3K5 | 0.51575936 |
93 | CAMKK1 | 0.51227364 |
94 | PDPK1 | 0.49636758 |
95 | TGFBR2 | 0.49582846 |
96 | ACVR1B | 0.48052508 |
97 | MAP3K6 | 0.46600924 |
98 | CDK4 | 0.46492860 |
99 | EPHA4 | 0.46064938 |
100 | PTK2 | 0.45823148 |
101 | CSNK1G1 | 0.45313816 |
102 | GRK1 | 0.44919116 |
103 | IGF1R | 0.42997833 |
104 | SGK2 | 0.40295211 |
105 | SRC | 0.40079547 |
106 | CSNK1E | 0.39892845 |
107 | MAP2K1 | 0.39708911 |
108 | CSNK2A1 | 0.36452488 |
109 | PRKCG | 0.36279088 |
110 | RET | 0.36119065 |
111 | EGFR | 0.34692671 |
112 | CSNK1A1 | 0.34286126 |
113 | ICK | 0.33619782 |
114 | CSNK2A2 | 0.33613174 |
115 | MTOR | 0.31071088 |
116 | MAPK3 | 0.30888007 |
117 | PKN1 | 0.30170329 |
118 | PDK1 | 0.29902094 |
119 | AKT2 | 0.29789344 |
120 | IRAK1 | 0.29716772 |
121 | CAMK4 | 0.29210957 |
122 | AKT3 | 0.29000999 |
123 | IRAK2 | 0.28297607 |
124 | CHUK | 0.27633415 |
125 | BMX | 0.27632263 |
126 | LATS2 | 0.25338009 |
127 | ABL1 | 0.25269124 |
128 | PRKCA | 0.25128841 |
129 | MAP3K1 | 0.24533319 |
130 | SGK223 | 0.24418084 |
131 | SGK494 | 0.24418084 |
132 | IKBKB | 0.22989705 |
133 | CSNK1G2 | 0.22625619 |
134 | MAP2K2 | 0.21902004 |
135 | CSNK1G3 | 0.21099534 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.54377059 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55299364 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45771783 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37176695 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06334806 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76344210 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.69115412 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69033373 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63299292 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54852507 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47987189 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38561552 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35509928 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20154763 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16139224 |
16 | Peroxisome_Homo sapiens_hsa04146 | 2.09588245 |
17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.01724702 |
18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00221056 |
19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.99529749 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91174534 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90591656 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85596531 |
23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81564411 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78005656 |
25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77251956 |
26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75432636 |
27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74253287 |
28 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66096219 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61946374 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58508858 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56457008 |
32 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54689211 |
33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51595384 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50505883 |
35 | Bile secretion_Homo sapiens_hsa04976 | 1.48609606 |
36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43882962 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36860975 |
38 | * Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35545642 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34192934 |
40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33148683 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30531747 |
42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30403033 |
43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24814684 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20049386 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.19244986 |
46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18695277 |
47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13852639 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11385252 |
49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.02384927 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01445885 |
51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00109792 |
52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98355226 |
53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96964187 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96043497 |
55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93214359 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87744238 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84228964 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81092427 |
59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80562615 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.79594672 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70618668 |
62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67640768 |
63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65707466 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56676936 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51208003 |
66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45415043 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43943703 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43931699 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.39183798 |
70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27845449 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25445859 |
72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24120288 |
73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23260243 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.22136480 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21234355 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18246087 |
77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13608985 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06516261 |
79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.03529002 |
80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2714258 |
81 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2501292 |
82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2412388 |
83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2332577 |
84 | Amoebiasis_Homo sapiens_hsa05146 | -0.2260076 |
85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2183852 |
86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2165213 |
87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.2157198 |
88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2087297 |
89 | Pertussis_Homo sapiens_hsa05133 | -0.2085719 |
90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2028820 |
91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1908620 |
92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1839311 |
93 | Hepatitis C_Homo sapiens_hsa05160 | -0.1794905 |
94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1794569 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1693447 |
96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1507326 |
97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1456186 |
98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1397497 |
99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1348149 |
100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1266300 |
101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1171508 |
102 | Mineral absorption_Homo sapiens_hsa04978 | -0.0881600 |
103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0831212 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0764649 |
105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0640500 |
106 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0339986 |
107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0331575 |
108 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0069571 |